|
Index of reports
> Cases resulting in life threatening events (58)
> Cases with Dyspnoea (5)
Below is the selection of adverse event reports related to Crestor (Rosuvastatin) that includes cases resulting in life threatening events where reactions include dyspnoea.
Adverse event in 80 year old female receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-07-26
Patient: 80 year old female, weighing 53.1 kg (116.8 pounds)
Adverse reactions / side effects: Dyspnoea, Nausea, Chest Pain, Dizziness, Asthenia, Rash Pruritic
Adverse event resulted in: life threatening event
Suspect drug(s):
Crestor (Rosuvastatin)
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Allopurinol; Omepral; Euglucon; Cardenalin; Amlodin; Ticlopidine HCL; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-02-07
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
Adverse event in 62 year old male receiving Crestor (Rosuvastatin)
Reported by a individual with unspecified qualification from United States on 2007-01-30
Patient: 62 year old male, weighing 131.5 kg (289.4 pounds)
Adverse reactions / side effects: Myalgia, Dyspnoea, Fatigue, Arthralgia, Musculoskeletal Pain, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Crestor
Indication: Blood Cholesterol Increased
Start date: 2004-07-01
End date: 2005-01-01
Zocor
Dosage: 40 mg. one a day
Indication: Blood Cholesterol Increased
Start date: 2005-01-01
End date: 2006-11-11
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-01-30
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
|
